a 2023

De novo design of peptides that form transmembrane barrel pores killing antibiotic resistant bacteria

DEB, Rahul; Ivo KABELKA; Jan PŘIBYL and Robert VÁCHA

Basic information

Original name

De novo design of peptides that form transmembrane barrel pores killing antibiotic resistant bacteria

Name in Czech

De novo design peptidů, které tvoří transmembránové válcovité póry zabíjející bakterie odolné vůči antibiotikům

Authors

DEB, Rahul; Ivo KABELKA; Jan PŘIBYL and Robert VÁCHA

Edition

BPS Annual Meeting 2023, 2023

Other information

Language

English

Type of outcome

Konferenční abstrakta

Country of publisher

United States of America

Confidentiality degree

is not subject to a state or trade secret

References:

Marked to be transferred to RIV

Yes

RIV identification code

RIV/00216224:14740/23:00132296

Organization

Středoevropský technologický institut – Repository – Repository

Keywords (in Czech)

návrh antimikrobiálních peptidů; transmembránové nanopóry; mikroskopie atomárních sil, KryoEM

Keywords in English

antimicrobial peptide design; transmembrane nanopores; atomic force microscopy; CryoEM

Links

LM2018127, research and development project. LX22NPO5103, research and development project.
Changed: 3/11/2024 00:50, RNDr. Daniel Jakubík

Abstract

In the original language

De novo design of peptides that self-assemble into transmembrane barrel-like nanopores is challenging due to the complexity of several competing interactions involving peptides, lipids, water, and ions. We have develop a computational approach for the de novo design of α-helical peptides that self-assemble into stable transmembrane barrel pores with a central nano-sized functional channel. We formulate the previously missing design guidelines and report 52 sequence patterns that can be tuned for specific applications using the identified role of each residue. Atomic force microscopy, fluorescent dye leakage, and cryo-EM experiments confirm that the designed peptides form leaky membrane nanopores in vitro. Customized designed peptides act as antimicrobial agents able to kill even antibiotic-resistant ESKAPE bacteria at micromolar concentrations, while exhibiting low toxicity to human cells. The peptides and their assembled nanopore structures can be similarly fine-tuned for other medical and biotechnological applications.

Files attached